Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses

Preoperative evaluation of patients presenting with ovarian masses is challenging, partly due to shortcomings with the commonly used marker, CA-125. Ovarian cancer is associated with systemic coagulation activation.